Du Pont Phenytoin Assay and Calibrator
by E.I. Dupont DE Nemours & Co., Inc.
510(k) K863888
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK863888 | Date5 Nov 1986 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DIR
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.3250
- Advisory Committee
- Clinical Toxicology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Du Pont Phenytoin Assay and Calibrator is an in vitro diagnostic device classified under the nomenclature for Free Radical Assays, Cocaine, and related substances, specifically for clinical toxicology applications. It is designed to measure phenytoin concentrations in biological samples, aiding in the monitoring of therapeutic drug levels to ensure patient safety and treatment efficacy.
This device is supplied as a kit for laboratory use and is intended for single-use only. It requires no special storage conditions beyond standard laboratory practices and is not intended for MRI environments. The assay and calibrator are regulated under FDA 510(k) clearance (K863888) with a classification as a Class II device under regulation 862.3250, and it was determined to be substantially equivalent to a predicate device in 1986.
Other devices from E.I. Dupont DE Nemours & Co., Inc.
Questions
AI-generated answers, 19 Sep 2026
What clinical area is this phenytoin assay primarily used for, and how does it help patients?
This assay is designed for clinical toxicology, specifically to measure phenytoin concentrations in biological samples like blood or serum. It aids in monitoring therapeutic drug levels to ensure patients remain within safe and effective dosage ranges, reducing the risk of toxicity or subtherapeutic outcomes during epilepsy treatment or other conditions requiring phenytoin therapy.
Is this kit reusable, or is it meant for single-use only? How should it be stored?
The kit is intended for single-use only, meaning each assay and calibrator set should not be reused after opening. Storage requires only standard laboratory conditions—no special refrigeration or environmental controls are specified, but it should be kept in a clean, dry environment away from direct sunlight or extreme temperatures.
What regulatory pathway was followed for this device, and when was it cleared?
This device followed the FDA 510(k) clearance process, specifically a *Traditional* review route, and was determined to be substantially equivalent to a predicate device. It received clearance on November 5, 1986, under the classification of a Class II device (regulation 862.3250) for Free Radical Assays, Cocaine, and related substances in clinical toxicology.
Can this assay be used in environments with MRI machines, or are there any restrictions?
The device is not intended for use in MRI environments. While the kit itself does not contain metallic components that would interfere with MRI, the manufacturer explicitly excludes its use in such settings, likely due to potential contamination risks or procedural incompatibilities in clinical toxicology labs near MRI facilities.